13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 76 holding rows worth $2,304,694,420.
- Accession
- 0001104659-23-060787
- Filer
- CIK 1425738
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 76 entries on the cover page, a total value of $2,304,694,420 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,304,694,420 with VALUE read as dollars as filed, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 18,346,861 | $203,466,688 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 1,913,280 | $153,177,197 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 4,205,206 | $102,312,662 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 5,582,105 | $86,243,522 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 2,044,389 | $78,218,323 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 2,925,648 | $77,822,237 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 12,957,222 | $73,856,165 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 2,410,769 | $71,431,085 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,879,739 | $67,633,009 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 3,811,988 | $67,319,708 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 6,067,918 | $54,853,979 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 187,992 | $52,391,490 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 1,186,418 | $51,704,096 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,612,094 | $49,362,318 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 335,159 | $49,043,816 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 130,540 | $48,636,593 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,325,832 | $47,451,527 | dollars as filed | |
| IGM BIOSCIENCES INC | 449585108 | COM | 3,334,355 | $45,814,038 | dollars as filed | |
| OAK STR HEALTH INC | 67181A107 | COM | 1,061,295 | $41,050,891 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 610,304 | $40,103,076 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 336,048 | $39,042,057 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 136,464 | $38,956,378 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 4,145,396 | $34,531,149 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 335,170 | $32,591,931 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 231,595 | $31,920,739 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 449,442 | $31,150,825 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 1,640,725 | $31,026,110 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 8,046,217 | $30,897,473 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 66,398 | $30,530,464 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 815,774 | $27,328,429 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 1,831,608 | $26,558,316 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 13,565,249 | $26,452,236 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 52,079 | $25,282,271 | dollars as filed | |
| AUGMEDIX INC | 05105P107 | COM | 14,380,327 | $25,021,769 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 3,124,226 | $24,993,808 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,533,050 | $24,925,212 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 1,992,843 | $24,511,969 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,749,384 | $24,414,530 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 901,932 | $23,360,039 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 115,328 | $23,275,497 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,317,031 | $20,427,151 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 6,926,926 | $19,256,854 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 277,351 | $17,531,357 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 5,619,914 | $16,522,547 | dollars as filed | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 5,612,056 | $16,274,962 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 1,120,679 | $16,160,191 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 71,657 | $14,251,861 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 8,031,094 | $14,054,415 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 900,000 | $13,707,000 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 3,503,190 | $13,487,282 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 688,132 | $12,627,222 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,286,177 | $10,173,488 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 34,604,516 | $9,917,654 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 171,780 | $8,594,153 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 33,496 | $7,789,495 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 1,907,969 | $7,517,398 | dollars as filed | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 19,808,234 | $5,577,999 | dollars as filed | |
| GRIFOLS S A | 398438408 | SP ADR REP B NVT | 720,784 | $5,312,178 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,031,009 | $5,031,475 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 1,870,839 | $4,770,639 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,074,372 | $3,443,458 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 2,280,403 | $3,078,544 | dollars as filed | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,487,495 | $3,034,490 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 586,977 | $2,653,136 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 274,252 | $2,268,064 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 2,552,949 | $1,878,970 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 1,440,725 | $1,728,870 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 1,046,587 | $1,705,937 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,608,089 | $1,539,745 | dollars as filed | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 1,847,600 | $1,293,320 | dollars as filed | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 373,244 | $1,104,802 | dollars as filed | |
| SONENDO INC | 835431107 | Common Stocks | 498,131 | $996,262 | dollars as filed | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 658,336 | $987,504 | dollars as filed | |
| CYTOSORBENTS CORP | 23283X206 | CMN | 181,639 | $612,123 | dollars as filed | |
| ATRECA INC | 04965G109 | COM | 442,653 | $504,624 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 318,082 | $215,628 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-060787 | this filing | 2023-05-15 | acceptance time not in the bulk data set |